{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:52:20Z","timestamp":1789177940266,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T00:00:00Z","timestamp":1410480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10096-014-2241-5","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T19:07:54Z","timestamp":1414696074000},"page":"349-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome"],"prefix":"10.1007","volume":"34","author":[{"given":"Y. P.","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.\u2010J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-M.","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-N.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-O.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-H.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,12]]},"reference":[{"issue":"41","key":"2241_CR1","doi-asserted-by":"crossref","first-page":"19688","DOI":"10.2807\/ese.15.41.19688-en","volume":"15","author":"R K\u00f6ck","year":"2010","unstructured":"K\u00f6ck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torn\u00e9 A, Witte W, Friedrich AW (2010) Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15(41):19688","journal-title":"Euro Surveill"},{"issue":"9","key":"2241_CR2","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/379021","volume":"37","author":"EC Nannini","year":"2003","unstructured":"Nannini EC, Singh KV, Murray BE (2003) Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin Infect Dis 37(9):1194\u20131198","journal-title":"Clin Infect Dis"},{"issue":"Suppl","key":"2241_CR3","doi-asserted-by":"crossref","first-page":"S386","DOI":"10.1093\/infdis\/128.Supplement_2.S386","volume":"128","author":"EL Quinn","year":"1973","unstructured":"Quinn EL, Pohlod D, Madhavan T, Burch K, Fisher E, Cox F (1973) Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis. J Infect Dis 128(Suppl):S386\u2013S389","journal-title":"J Infect Dis"},{"issue":"3","key":"2241_CR4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/clinids\/11.3.361","volume":"11","author":"I Brook","year":"1989","unstructured":"Brook I (1989) Inoculum effect. Rev Infect Dis 11(3):361\u2013368","journal-title":"Rev Infect Dis"},{"issue":"8","key":"2241_CR5","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/AAC.00052-12","volume":"56","author":"DJ Livorsi","year":"2012","unstructured":"Livorsi DJ, Crispell E, Satola SW, Burd EM, Jerris R, Wang YF, Farley MM (2012) Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 56(8):4474\u20134477","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2241_CR6","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.00317-09","volume":"53","author":"EC Nannini","year":"2009","unstructured":"Nannini EC, Stryjewski ME, Singh KV, Bourgogne A, Rude TH, Corey GR, Fowler VG Jr, Murray BE (2009) Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother 53(8):3437\u20133441","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"2241_CR7","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/AAC.42.12.3163","volume":"42","author":"RK Voladri","year":"1998","unstructured":"Voladri RK, Kernodle DS (1998) Characterization of a chromosomal gene encoding type B beta-lactamase in phage group II isolates of Staphylococcus aureus. Antimicrob Agents Chemother 42(12):3163\u20133168","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2241_CR8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/AAC.34.3.420","volume":"34","author":"DS Kernodle","year":"1990","unstructured":"Kernodle DS, McGraw PA, Stratton CW, Kaiser AB (1990) Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants. Antimicrob Agents Chemother 34(3):420\u2013425","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2241_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/infdis\/159.1.103","volume":"159","author":"DS Kernodle","year":"1989","unstructured":"Kernodle DS, Stratton CW, McMurray LW, Chipley JR, McGraw PA (1989) Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles. J Infect Dis 159(1):103\u2013108","journal-title":"J Infect Dis"},{"issue":"12","key":"2241_CR10","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1093\/jac\/dkt254","volume":"68","author":"S Rinc\u00f3n","year":"2013","unstructured":"Rinc\u00f3n S, Reyes J, Carvajal LP, Rojas N, Cort\u00e9s F, Panesso D, Guzm\u00e1n M, Zurita J, Adachi JA, Murray BE, Nannini EC, Arias CA (2013) Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals. J Antimicrob Chemother 68(12):2773\u20132778","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2241_CR11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MD.0b013e318289ff1e","volume":"92","author":"YP Chong","year":"2013","unstructured":"Chong YP, Park SJ, Kim HS, Kim ES, Kim MN, Park KH, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS (2013) Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates. Medicine (Baltimore) 92(2):98\u2013108","journal-title":"Medicine (Baltimore)"},{"key":"2241_CR12","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2012) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard\u2014ninth edition. CLSI document M07-A9. CLSI, Wayne, PA"},{"issue":"5","key":"2241_CR13","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/AAC.01325-09","volume":"54","author":"EC Nannini","year":"2010","unstructured":"Nannini EC, Stryjewski ME, Singh KV, Rude TH, Corey GR, Fowler VG Jr, Murray BE (2010) Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 54(5):2206\u20132208","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2241_CR14","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/JCM.33.6.1665-1667.1995","volume":"33","author":"GV Doern","year":"1995","unstructured":"Doern GV, Jones RN, Gerlach EH, Washington JA, Biedenbach DJ, Brueggemann A, Erwin ME, Knapp C, Raymond J (1995) Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1. J Clin Microbiol 33(6):1665\u20131667","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2241_CR15","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/JCM.38.3.1008-1015.2000","volume":"38","author":"MC Enright","year":"2000","unstructured":"Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38(3):1008\u20131015","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2241_CR16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/520088","volume":"196","author":"VG Fowler Jr","year":"2007","unstructured":"Fowler VG Jr, Nelson CL, McIntyre LM, Kreiswirth BN, Monk A, Archer GL, Federspiel J, Naidich S, Remortel B, Rude T, Brown P, Reller LB, Corey GR, Gill SR (2007) Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 196(5):738\u2013747","journal-title":"J Infect Dis"},{"issue":"3","key":"2241_CR17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","volume":"16","author":"JS Garner","year":"1988","unstructured":"Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16(3):128\u2013140","journal-title":"Am J Infect Control"},{"issue":"4","key":"2241_CR18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30(4):633\u2013638","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2241_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1\u201345","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2241_CR20","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1128\/AAC.00485-11","volume":"55","author":"S Lee","year":"2011","unstructured":"Lee S, Choe PG, Song KH, Park SW, Kim HB, Kim NJ, Kim EC, Park WB, Oh MD (2011) Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia? Antimicrob Agents Chemother 55(11):5122\u20135126","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2241_CR21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.1977.03270330059022","volume":"237","author":"RE Bryant","year":"1977","unstructured":"Bryant RE, Alford RH (1977) Unsuccessful treatment of staphylococcal endocarditis with cefazolin. JAMA 237(6):569\u2013570","journal-title":"JAMA"},{"issue":"1","key":"2241_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/430833","volume":"41","author":"ML Fern\u00e1ndez-Guerrero","year":"2005","unstructured":"Fern\u00e1ndez-Guerrero ML, de G\u00f3rgolas M (2005) Cefazolin therapy for Staphylococcus aureus bacteremia. Clin Infect Dis 41(1):127","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-014-2241-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-014-2241-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-014-2241-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T08:27:19Z","timestamp":1598430439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-014-2241-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,12]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2241"],"URL":"https:\/\/doi.org\/10.1007\/s10096-014-2241-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,12]]}}}